Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

USG evaluatıon of COVID-19 Related Muscle Mass Change in the ICU

Authors not listed

Ondokuz Mayıs University · 2021

Abstract

Critical illness myopathy and neuropathy are associated with prolonged mechanical ventilation, resulting in increased morbidity and mortality in intensive care units, .the investigators aimed to determine the decrease in muscle mass and risk factors that are important causes for the development of myopathy in COVID-19 (+) patients followed in intensive care unit. The study will also evaluate the relationships of patients withthe investigators intensive care-associated muscle weakness (ICU-AW) with other intensive care patient weight scores (SOFA, APACHE II, q SOFA). Sensitivity of anthropometric measurements and ultrasonographic measurements will be compared in the evaluation of sarcopenia. The length of hospital stay, mechanical ventilation time, patient outcomes (mortality/morbidity) information of patients with COVID-19 pneumonia followed in the intensive care unit will be evaluated.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-11-14 MST

Cite this

APA
Anonymous. (2021). USG evaluatıon of COVID-19 Related Muscle Mass Change in the ICU. <em>Ondokuz Mayıs University</em>. https://clinicaltrials.gov/study/NCT05008562
Vancouver
Anonymous. USG evaluatıon of COVID-19 Related Muscle Mass Change in the ICU. Ondokuz Mayıs University. 2021.
BibTeX
@misc{anon2021USGeva, title = {USG evaluatıon of COVID-19 Related Muscle Mass Change in the ICU}, author = {Anonymous}, journal = {Ondokuz Mayıs University}, year = {2021}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings